Interim Impact: The Rise of “Fractional” Medical Affairs Roles in Pharma’s New Reality
In this episode, Tom Caravela and Daniel Snyder explore the rise of fractional medical affairs roles in the post-COVID era. They define interim and fractional positions, highlighting how they benefit both job seekers and companies. The discussion covers the increase in these roles, company utilization of interim talent, disadvantages, and compensation expectations, offering negotiation tips for candidates. They also discuss the future of fractional staffing, market trends, and the gig economy's impact on pharma and biotech. The episode ends with cost-effective strategies and gratitude to the audience.
Key Points
- Fractional medical affairs roles offer a cost-effective solution for pharmaceutical companies to address specific project needs without committing to full-time hires. The rise in fractional positions is driven by economic uncertainties and the need for companies to streamline operations while still advancing critical projects. Engaging in fractional work can help professionals bridge employment gaps, expand their networks, and gain new therapeutic experience, making them more attractive in the job market.
Chapters
0:00 | |
0:41 | |
2:41 | |
5:06 | |
12:44 | |
22:29 | |
30:12 | |
32:39 | |
35:12 | |
37:06 |
Transcript
Loading transcript...
- / -